SOPHiA GENETICS S.A. (SOPH) Stock Overview
Explore SOPHiA GENETICS S.A.’s financial performance, market position, analyst ratings, and future outlook.
SOPHiA GENETICS S.A. (SOPH)
Key Financials
Key Financials
Market Cap
367.8M
P/E Ratio
-4.55
EPS (TTM)
$-0.52
ROE
-1.41%
SOPH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of SOPHiA GENETICS S.A. (SOPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 50.59, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.88.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.55 and a market capitalization of 367.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.